Delayed Release IBD Treatment Composition
Summary
Aihol Corporation filed patent application US20260090996A1 for a delayed-release oral pharmaceutical composition containing mesalamine and hyaluronan layers for treating inflammatory bowel disease. The USPTO published the application on April 2, 2026, with Application No. 19399068 and a filing date of November 24, 2025. This patent covers novel multi-layer coating technology for targeted drug delivery to the colon.
What changed
The USPTO published patent application US20260090996A1 for a delayed-release oral pharmaceutical composition for inflammatory bowel disease (IBD) treatment. The invention involves a layered formulation with a mesalamine core layer, hyaluronan layer, and at least one coating layer designed for targeted colonic delivery. The patent claims the specific combination and configuration of these layers for therapeutic use.
No compliance actions are required from pharmaceutical manufacturers, healthcare providers, or other entities. This is a patent application publication, not a regulatory requirement or enforcement action. Entities developing similar delayed-release formulations for IBD may wish to conduct freedom-to-operate analyses to assess potential infringement risks. The patent application provides public notice of the claimed invention for competitive intelligence purposes.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DELAYED RELEASE ORAL PHARMACEUTICAL COMPOSITION
Application US20260090996A1 Kind: A1 Apr 02, 2026
Assignee
Aihol Corporation
Inventors
Tsung-Chung WU, Yu-Chih CHEN
Abstract
Disclosed herein are compositions and methods for the treatment of inflammatory bowel disease. According to some embodiments, the compositions and methods involve the use of a delayed-release formulation containing a mesalamine layer, a hyaluronan layer, and at least one coating layer.
CPC Classifications
A61K 9/4816 A61K 9/0002 A61K 9/0053 A61K 9/4891 A61K 31/60 A61K 31/728 A61P 1/04
Filing Date
2025-11-24
Application No.
19399068
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.